Apira Science has received clearance to sell and distribute the iGrow hair growth system in Brazil, bringing the benefits of low-level light therapy (LLLT) to the homes of consumers in one of the largest beauty markets in the world.
The iGrow is the first wearable, home use laser device to be cleared by ANVISA, the Brazilian regulatory agency responsible for approving cosmetics, health services, medical devices, and more.
Apira will distribute the iGrow in Brazil in partnership with Onderma, a leading distributor of dermatological products.
With ANVISA clearance, iGrow is looking to capitalize on a booming market for hair care products among Brazilian consumers.
The country represents the second largest hair care market in the world, after the U.S., and the third largest consumer market for beauty products overall. In 2014, women alone spent more than $7.7 billion on hair care.
“Brazilian men and women alike dedicate much time, effort, and money into maintaining healthy hair,” said Jeff Braile, president of Apira Science. “By achieving ANVISA clearance for the iGrow and partnering with Onderma we’re giving consumers in this country a clinically proven LLLT treatment to fight hereditary hair loss and grow thicker, healthier hair.”
The iGrow Hair Growth System is an innovative, safe, and effective hands-free LLLT hair growth device cleared by the FDA for at-home use. In clinical studies, the iGrow’s patented red light technology, which consists of a highly productive combination of red laser and LED diodes, increased hair growth 37 percent after 16 weeks of therapy, and nearly doubled total hair growth 10 weeks faster than hand-held laser combs and brushes.
“Onderma is committed to bringing Brazilian shoppers some of the best existing dermatological products in the world, and the iGrow fits well within that category,” said Leandro Costa, president of Onderma. “As a wearable LLLT device, iGrow is a convenient treatment for individuals looking to improve the quantity and quality of hair.”
The iGrow has received clearances from dozens of countries across the globe, including the United States, Canada, Mexico, Korea, Singapore, and China. iGrow is also available to consumers in all 28 European Union nations, Turkey, India, and the United Kingdom.